Abstract
Significant advances in the areas of identification of disease susceptibility genes and gene transfer technologies have fueled new initiatives in cellular engineering as a means for treating metabolic disease. This article utilizes new findings from such work as the blueprint for a discussion of the prospects for gene therapy in diabetes mellitus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Miller, A.D. 1992. Human gene therapy comes of age. Nature 357: 455–460.
Ledley, F.D. 1990. Clinical application of somatic gene therapy in inborn errors of metabolism. J. Inher. Metab. Dis. 13: 597–616.
Lacy, P.E. and Scharp, D.W. 1986. Islet transplantation in treating diabetes. Ann. Rev. Med. 37: 33–406.
Posselt, A.M., Barker, C.F., Tomaszewski, J.E., Markmann, J.F., Choti, M.A. and Naji, A. 1990. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 249: 1293–1295.
Sullivan, S.J., Maki, T., Borland, K.M., Mahoney, M.D., Solomon, B.A., Muller, T.E., Monaco, A.P. and Chick, W.L. 1991. Biohybrid artificial pancreas: Long-term implantation studies in diabetic, pancreatectomized dogs. Science 252: 718–721.
Lacy, P.F., Hegre, O.D., Gerasimidi-Vazeou, A., Gentile, F.T. and Dionne, K.E. 1991. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254: 1782–1785.
Lanza, R.P., Borland, K.M., Lodge, P., Carretta, M., Sullivan, S.J., Muller, T.E., Solomon, B.A., Maki, T., Monaco, A.P. and chick, W.L. 1992. Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 41: 886–889.
Chick, W.L., Warren, S., Chute, R.N., Like, A.A., Lauris, V. and Kitchen, K.C. 1977. A transplantable insulinoma in the rat. Proc. Natl. Acad. Sci. USA 74: 628–632.
Efrat, S., Linde, S., Kofod, H., Spector, D., Delannoy, M., Grant, S., Hanaban, D. and Baekkeskov, S. 1988. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc. Natl. Acad. Sci. USA 85: 9037–9041.
Miyazaki, J.I., Araki, K., Yamato, E., Ikegami, H., Asano, T., Shibasaki, Y., Oka, Y. and Yamamura, K.I. 1990. Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: Special reference to expression of glucose transporter isoforms. Endocrinology 127: 126–132.
Meglasson, M.D. and Matschinsky, F.M. 1986. Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes/Metabolism Rev. 2: 163–214.
Prentki, M. and Matschinsky, F.M. 1987. Ca2+, cAMP, and phospholipid derived messengers in coupling, mechanisms of insulin secretion. Physiol. Rev. 67: 1185–1248.
Turk, J., Wolf, B.A. and McDaniel, M.L. 1987. The role of phospholipid-derived mediators including arachidonic acid, its metabolites, and inositoltrisphosphate and of intracellular Ca2+ in glucose-induced insulin secretion by pancreatic islets. Prog. Lipid Res. 26: 125–181.
MacDonald, M.J. 1990. Elusive proximal signals of β-cells for insulin secretion. Diabetes 39: 1461–1466.
Ghosh, A., Ronner, P., Cheong, E., Khalid, P. and Matschinsky, F.M. 1991. The role of ATP and free ADP in metabolic coupling during fuel-stimulated insulin release from islet β-cells in the isolated perfused pancreas. J. Biol. Chem. 266: 22887–22892.
Prentki, M., Vischer, S., Glennon, M.C., Regazzi, R., Deeney, J.T. and Corkey, B.E. 1992. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J. Biol. Chem. 267: 5802–5810.
Bell, G.I., Kayano, T., Buse, J.B., Burant, C.F., Takeda, J., Lin, D., Fukumoto, H. and Seino, S. 1990. Molecular biology of mammalian glucose transporters. Diabetes Care 13: 198–208.
Thorens, B., Charron, M.J. and Lodish, H.F. 1990. Molecular physiology of glucose transporters. Diabetes Care 13: 209–218.
Unger, R.H. 1991. Diabetic hyperglycemia: Link to impaired glucose transport in pancreatic β-cells. Science 251: 1200–1205.
Clark, S.A., Burnham, B.L. and Chick, W.L. 1990. Modulation of glucose-induced insulin secretion from a rat clonal β-cell line. Endocrinology 127: 2779–2788.
Whitesell, R.R., Powers, A.C., Regen, D.M. and Abumrad, N.A. 1991. Transport and metabolism of glucose in an insulin-secreting cell line, βTC-1. Biochemistry 30: 11560–11566.
Fleischer, N., Leiser, M., Surana, M., Tal, M. and Efrat, S. 1992. βTC7, a murine β-cell line with correctly regulated insulin secretion. Diabetes 41: 5A (abstract).
German, M.S. and Rutter, W.J. 1991. The role of the glucose transporter and glucokinase in β-cell transcriptional response to glucose. Diabetes 40: 163A (abstract).
Madsen, O.D., Andersen, L.C., Michelsen, B., Owerbach, D., Larsson, L.I., Lernmark, A. and Steiner, D.F. 1988. Tissue-specifIc expression of transfected human insulin genes in pluripotent clonal rat insulinoma lines induced during passage in vivo. Proc. Natl. Acad. Sci. USA 85: 6652–6656.
Moore, H.P., Walker, M.D., Lee, F. and Kelly, R.B. 1983. Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell 35: 531–538.
Smeekens, S.P. and Steiner, D.F. 1990. Identification of a human insulin-oma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2. J. Biol. Chem. 265: 2997–3000.
Hakes, D.J., Birch, N.P., Mezey, A. and Dixon, J.E. 1991. Isolation of two complementary deoxyribonucleic acid clones from a rat insulinoma cell linebased on similarities to Kex2 and furin sequences and the specific localization of each transcript to endocrine and neuroendocrine tissues in rat. Endocrinology 129: 3053–3063.
Selden, R.F., Skoskiewicz, M.J., Russell, P.S. and Goodman, H.M. 1987. Regulation of insulin gene expression: Implications for gene therapy. N. Engl. J. Med. 317: 1067–1076.
Luini, A., Lewis, D., Guild, S., Corda, D. and Axelrod, J. 1985. Hormone secretagogues increase cytosolic calcium by increasing cAMP in corticotropin-secreting cells. Proc. Natl. Acad. Sci. USA 82: 8034–8038.
Hughes, S.D., Quaade, C., Milburn, J.L., Cassidy, L.C. and Newgard, C.B. 1991. Expression of normal and novel glucokinase mRNAs in anterior pituitary and islet cells. J. Biol. Chem. 266: 4521–4530.
Hughes, S.D., Johnson, J.H., Quaade, C. and Newgard, C.B. 1992. Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells. Proc. Natl. Acad. Sci. USA 89: 688–692.
Hughes, S.D., Quaade, C., Johnson, J.H., Ferber, S. and Newgard, C.B. 1992. Divergent effects of glucose on GLUT-1 versus GLUT-2 transfected AtT-20ins cells despite similar rates of glucose usage. Diabetes 41: 103A (abstract).
Ferber, S., Gross, D.J., Villa-Komaroff, L., Danehy, F., Vollenweider, F., Meyer, K., Loeken, M.R., Kahn, C.R. and Halban, P.A. 1991. Heterogeneity of expression and secretion of native and mutant [Asp Bl0] insulin in AtT-20 cells. Mol. Endocrinol. 5: 319–326.
Waddell, I.D. and Burchell, A. 1988. The microsomal glucose-6-phosphatase enzyme of pancreatic islets. Biochem. J. 255: 471–476.
Khan, A., Chandramouli, V., Ostenson, C.G., Low, H., Landau, B.R. and Efendic, S. 1990. Glucose cycling in islets from healthy and diabetic rats. Diabetes 39: 456–459.
Friedmann, T. 1989. Progress toward human gene therapy. Science 244: 1275–1281.
Scharfmann, R., Axelrod, J.H. and Verma, I.M. 1991. Long term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88: 4626–4630.
Rosen, O.M. 1987. After insulin binds. Science 237: 1452–1458.
Bell, G.I. 1991. Molecular defects in diabetes mellitus. Diabetes 40: 413–422.
Garvey, W.T. 1992. Glucose transport and NIDDM. Diabetes Care 15: 396–417.
Rothman, D.L., Shulman, R.G. and Shulman, G.I. 1992. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate: Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin dependent diabetes mellitus. J. Clin. Invest. 89: 1069–1075.
Wolff, J.A., Malone, R.W., Williams, P., Chang, W., Ascadi, G., Jani, A. and Felgnes, P.L. 1990. Direct gene transfer into mouse muscle in vivo. Science 247: 1465–1468.
Barr, E. and Leiden, J.M. 1991. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254: 1507–1509.
Dhawan, J., Pan, L.C., Pavlath, G.K., Travis, M.A., Lanctot, A.M. and Blau, H.M. 1991. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254: 1509–1512.
Matsutani, A., Koranyi, L., Cox, N. and Permutt, M.A. 1990. Polymorphisms of GLUT-2 and GLUT-4 genes: Use in evaluation of genetic susceptibility to NIDDM in blacks. Diabetes 39: 1534–1542.
Alcolado, J.C., Baroni, M.G. and Li, S.R. 1991. Association between a restriction fragment length polymorphism at the liver/islet cell (GLUT-2) glucose transporter and familial type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34: 234–236.
Frougel, P., Vaxillaire, M., Sun, F., Vehlo, G., Zouali, H., Butel, M.O., Lesage, S., Vionnet, N., Clement, K., Fougerousse, F., Tanizawa, Y., Weissenbach, J., Beckmann, J.S., Lathrop, G.M., Passa, P., Permutt, M.A. and Cohen, D. 1992. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin dependent diabetes mellitus. Nature 356: 162–164.
Vionnet, N., Stoffel, M., Takeda, J., Yasuda, K., Bell, G.I., Zouali, H., Lesage, S., Velho, G., Iris, F., Passa, P., Frouguel, P. and Cohen, D. 1992. Nonsense mutation in the glucokinase gene causes early-onset non-insulin dependent diabetes mellitus. Nature 356: 721–722.
Stoffel, M., Froguel, P., Takeda, J., Zouali, H., Vionnet, N., Nishi, S., Weber, I.T., Harrison, R.W., Pilkis, S.J, Lesage, S., Vaxillaire, M., Velho, G., Sun, F., Iris, F., Passa, P., Cohen, D. and Bell, G.I. 1992. Human glucokinase gene: Isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc. Natl. Acad. Sci. USA In press.
Magnuson, M.A. 1990. Glucokinase gene structure: Functional implications of molecular genetic studies. Diabetes 39: 523–527.
Newgard, C.B., Quaade, C., Hughes, S.D. and Milburn, J.L. 1990. Glucokinase and glucose transporter expression in liver and islets: Implications for control of glucose homeostasis. Biochem. Soc. Trans. 18: 851–853.
Tanizawa, Y., Matsutani, A., Chiu, K.C. and Permutt, M.A. 1992. Isolation of the human glucokinase gene, identification of polymorphic micro-satellite repeats, and direct genomic analysis in NIDDM patients. Diabetes 41: 14A (abstract).
Welsh, M., Claesson-Welsh, L., Hallberg, A., Welsh, N., Betsholtz, C., Arkhammar, P., Nilsson, T., Heldin, C.H. and Berggren, P.O. 1990. Coexpression of the platelet-derived growth factor (PDGF) B chain and the PDGF β receptor in isolated pancreatic islet cells stimulates DNA synthesis. Proc. Natl. Acad. Sci. USA 87: 5807–5811.
Rosenfeld, M.A., Yoshimura, K., Trapnell, B.C., Yoneyama, K., Rosenthal, E.R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L.E., Startford-Perricaudet, L., Perricaudet, M., Guggino, W.B., Pavirani, A., Lecocq, J.P. and Crystal, R.G. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68: 143–155.
Van Doren, K., Hanahan, D. and Gluzman, Y. 1984. Infection of eucaryotic cells by helper-independent recombinant adenoviruses: Early region 1 is not obligatory for integration of viral DNA. J. Virol. 50: 606–614.
Gomez-Foix, A.M., Coats, W.S., Baque, S., Gerard, R. and Newgard, C.B. 1992. Adenovirus-mediated muscle glycogen phosphorylase gene transfer into primary hepatocytes causes altered regulation of glycogen metabolism. Submitted.
Coats, W.S., Browner, M.F., Fletterick, R.J. and Newgard, C.B. 1991. An engineered liver glycogen phosphorylase with AMP allosteric activation. J. Biol. Chem. 266: 16113–16119.
Ponder, K.P., Gupta, S., Leland, F., Darlington, G., Finegold, M., DeMayo, J., Ledley, F.D., Chowdhury, J.R. and Woo, S.L.C. 1991. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc. Natl. Acad. Sci. USA 88: 1217–1221.
Wilson, J.M., Chowdhury, N.R., Grossman, M., Wajsman, R., Epstein, A., Mulligan, R.C. and Chowdhury, J.R. 1990. Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc. Nail Acad. Sci. USA 87: 8437–8441.
Liu, T.J., Kay, M.A., Darlington, G.J. and Woo, S.L.C. 1992. Reconstitution of enzymatic activity in hepatocytes of phenylalanine hydroxylase-deficient mice. Somat. Cell Mol. Genet. 18: 89–96.
Wu, C.H., Wilson, J.M. and Wu, G.Y. 1989. Targeting genes: Delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J. Biol. Chem. 264: 16985–16987.
Stratford-Perricaudet, L.D., Levrero, M., Chasse, J.-F., Perricaudet, M. and Briand, P. 1990. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene. Ther. 1: 241–256.
Gerard, R.D. and Meidell, R.S. 1991. The use of recombinant adenovirus vectors to deliver genes into vascular endothelial cells. J. Cell. Biochem. Suppl. 15C: 133 (abstract).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Newgard, C. Cellular Engineering for the Treatment of Metabolic Disorders: Prospects for Therapy in Diabetes. Nat Biotechnol 10, 1112–1120 (1992). https://doi.org/10.1038/nbt1092-1112
Issue Date:
DOI: https://doi.org/10.1038/nbt1092-1112